These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 7912675)
1. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells. Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675 [TBL] [Abstract][Full Text] [Related]
2. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Correa I; Corral L; Raulet DH Eur J Immunol; 1994 Jun; 24(6):1323-31. PubMed ID: 8206092 [TBL] [Abstract][Full Text] [Related]
3. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950 [TBL] [Abstract][Full Text] [Related]
5. The regulatory role of CD45 on rat NK cells in target cell lysis. Giezeman-Smits KM; Gorter A; van Vlierberghe RL; v Eendenburg JD; Eggermont AM; Fleuren GJ; Kuppen PJ J Immunol; 1999 Jul; 163(1):71-6. PubMed ID: 10384101 [TBL] [Abstract][Full Text] [Related]
6. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198 [TBL] [Abstract][Full Text] [Related]
7. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
8. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
9. Preincubation of tumor cells with the anti-(MHC) class I antibody OX18 enhances tumor cell lysis by interleukin-2-activated NK cells. Smits KM; Kuppen PJ; Eggermont AM; Fleuren GJ Transplant Proc; 1993 Oct; 25(5):2806-7. PubMed ID: 8212242 [No Abstract] [Full Text] [Related]
10. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. Aramburu J; Balboa MA; Izquierdo M; López-Botet M J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071 [TBL] [Abstract][Full Text] [Related]
11. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Komatsu F; Kajiwara M Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151 [TBL] [Abstract][Full Text] [Related]
12. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Karlhofer FM; Ribaudo RK; Yokoyama WM Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533 [TBL] [Abstract][Full Text] [Related]
13. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression. Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970 [TBL] [Abstract][Full Text] [Related]
14. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Chong AS; Boussy IA; Jiang XL; Lamas M; Graf LH Cell Immunol; 1994 Aug; 157(1):92-105. PubMed ID: 7518755 [TBL] [Abstract][Full Text] [Related]
15. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition. Kraus E; Lambracht D; Wonigeit K; Hünig T Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942 [TBL] [Abstract][Full Text] [Related]
16. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. Kaufman DS; Schoon RA; Leibson PJ J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986 [TBL] [Abstract][Full Text] [Related]
17. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells. Lobo PI; Spencer CE J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268 [TBL] [Abstract][Full Text] [Related]
18. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Reiter Z Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. Karlhofer FM; Yokoyama WM J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886 [TBL] [Abstract][Full Text] [Related]
20. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control. Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]